We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current JBPHF market cap is 233.57M. The company's latest EPS is CNY -0.4697 and P/E is -0.62.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 0 | 0 | 486.29M | 152.81M | 95.75M |
| Operating Income | -105.3M | -200.44M | 209.39M | -301.59M | -473.71M |
| Net Income | -149.21M | -424.81M | -1.51B | -301.19M | -371.86M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 473.6M | 363.33M | 1.87B | 1.72B | 1.57B |
| Total Liabilities | 570.84M | 833.41M | 81.15M | 84.75M | 292.12M |
| Total Equity | -97.25M | -470.08M | 1.79B | 1.64B | 1.28B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -79.89M | -113.03M | 78.83M | -147.49M | -292.42M |
| Investing | 14.58M | -273k | -215.56M | 161.67M | -686.32M |
| Financing | 356.83M | 929k | 1.28B | 109.06M | -9.85M |
| Market Cap | 233.57M |
| Price to Earnings Ratio | -0.62 |
| Price to Sales Ratio | 2.4 |
| Price to Cash Ratio | 0.18 |
| Price to Book Ratio | 0.18 |
| Dividend Yield | - |
| Shares Outstanding | 791.76M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -44.89% |
| 52 Week High | 0.5353 |
| 52 Week Low | 0.295 |
| Spread (Intraday) | 0.08 (27.61%) |
| Company Name | Jacobio Pharmaceuticals Group Company Ltd (PK) |
| Address |
walkers corporate limited george town KY1-9008 |
| Website | https://www.jacobiopharma.com |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
